DeutschNewstral
Article
bizjournals.com on 2021-10-12 18:00
Japanese biotech pays Albireo $135M for local liver disease drug rights
Related news
Japanese PM pays tribute to 'Japanese Schindler'israelnationalnews.com- FUK biotech signs $1bn deal to develop liver disease drugsft.com
- Cambridge biotech startup grabs $65M to tackle liver diseasebizjournals.com
Japanese tend to accrue liver fat, new study findsstaradvertiser.com
Japanese sushi disease spreading to the U.S.metro.us
New Orleans-based biotech startup acquired by Japanese companyneworleanscitybusiness.com- Japanese biotech firm Nobelpharma expands to Montgomery Countybizjournals.com
- Sucampo Pharmaceuticals closes $275 million deal for Japanese biotechbizjournals.com
- Boulder biotech makes pain-killer deal with Japanese firmbizjournals.com
- FJapanese biotech seeks to turn ‘brown gem’ into goldft.com
- Japanese electronics manufacturing firm Ricoh takes stake in Baltimore biotechbizjournals.com
Japanese Town Pays Couples to Have ChildrenKTLA 5- CNEH grant pays for Japanese adjunctcalvin.edu
Google pays tribute to Japanese scientist TsujimuraThe Times of India
Hacked Japanese Cryptocurrency Exchange Pays Back Customerswsj.com
Pharmaceuticals sector: Oxford biotech raises funds to make RNA treatments for liver diseaseFinancial Times- Dash for NASH trips up Gilead, but 'fatty liver disease' remains biotech targetbizjournals.com
- In race to defeat fatty liver disease, Peninsula biotech lines up next clinical trialbizjournals.com
Brewers toast alcohol-free beer boom as more Japanese embrace ‘liver rest days’South China Morning Post
New treatment keeps liver transplant patients healthy without immunosuppressants: Japanese researchersThe Japan Times